(NQ: )

N/A UNCHANGED

Last Price Updated: Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	2.300
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	N/A
Dividend Yield	N/A

Chart for (: )

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

Cempra Announces Preliminary Results of 2017 Stockholder Vote

November 03, 2017

Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and community settings to meet critical medical needs in the...

Melinta and Cempra Announce Accomplished Executive Leadership Team for Combined Organization

November 01, 2017

Melinta Therapeutics, Inc., a privately held company developing and commercializing novel antibiotics to treat serious bacterial infections, and Cempra, Inc. (Nasdaq:CEMP) today announced the executive...

Performance

More News

Melinta and Cempra Name Industry Leader Daniel Wechsler as President and Chief Executive Officer of the Combined Company

October 31, 2017

Hercules Capital Announces Fourth Quarter and Full-Year 2017 Financial Results and Quarterly Distribution of $0.31 per Share

February 22, 2018

Melinta Therapeutics Announces FDA Clearance of Antimicrobial Susceptibility Tests Concurrent with Baxdela Launch in the United States

October 30, 2017

Hercules Capital Achieves More Than $880 Million in New Commitments in 2017(1)

January 08, 2018

Melinta Therapeutics Publication Reinforces Baxdela Tolerability and Activity in Patients with MRSA Infections and Challenging Comorbidities

October 24, 2017

Hercules Announces Third Quarter 2017 Financial Results and Declares a $0.31 per Share Quarterly Distribution

November 02, 2017

Melinta Therapeutics’ Topical Radezolid Well Tolerated in Phase 1 Study for Treatment of Acne

October 10, 2017

Melinta Therapeutics Presents Outcomes of Baxdela Treatment of Gram-Positive and Gram-Negative Pathogens at IDWeek

October 04, 2017

Cempra and Melinta Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Merger

September 28, 2017

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.